MarketCap
Facebook
X
Telegram
The Mosaic Company Financial Ratios 2025-2008 | MOS
Brief overview of The Mosaic Company's valuation multiples
Ratios are assessed across five available annual reports in the 2021–2025 interval.
The valuation comparison uses P/E 21.58x (median 9.13x), EV/EBITDA 6.09x (median 4.34x), P/S 0.97x (median 0.95x). The combined multiple level is about 40.4% above the company's historical norm, leaving less valuation cushion.
The inverse P/E implies an earnings yield of 4.6%. This is not a dividend yield, but current earnings relative to market price.
End-period return metrics are ROE 4.5%, ROA 2.2%, ROCE 6.8%. Profitability remains low. Market valuation has limited fundamental support until resource returns improve.
Price, earnings and growth produce a PEG of 0.6x. A value below one indicates moderate pricing relative to expected growth.
The time from paying for inputs to receiving cash rose from 84.5 days to 97.6 days. Cash turnover slowed.
Overall picture
The Mosaic Company's multiples are demanding relative to current business quality. Material improvement is needed to justify them.
Annual Financial Ratios The Mosaic Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
21.6 | 42.4 | 9.1 | 5.1 | 9.1 | 12.9 | -7.3 | 26.1 | -89.0 | 36.4 | 8.6 | 17.7 | 12.1 | 12.1 | 12.0 | 24.0 | 10.7 | - |
P/S |
1.0 | 0.7 | 0.8 | 0.9 | 1.2 | 1.0 | 0.9 | 1.3 | 1.3 | 1.5 | 1.0 | 2.0 | 2.3 | 2.1 | 3.0 | - | - | - |
EPS |
1.7 | 0.6 | 3.5 | 10.2 | 4.3 | 1.8 | -2.8 | 1.2 | -0.3 | 0.8 | 2.8 | 2.7 | 4.4 | 4.4 | 5.6 | 1.9 | 5.3 | - |
EV (Enterprise Value) |
11.4 B | 7.14 B | 10.3 B | 17.4 B | 14 B | 8.04 B | 17.2 B | 20.9 B | 16.4 B | 17.4 B | 15.2 B | 23.4 B | 22.3 B | 24.2 B | 30.4 B | 17.3 B | 22.4 B | -1.96 B |
EBITDA per Share |
5.9 | 5.15 | 6.94 | 16.2 | 8.68 | 3.33 | 3.35 | 4.79 | 3.31 | 3.01 | 5.68 | 5.69 | 6.66 | 7.53 | 8.56 | 3.85 | 6.22 | - |
EV/EBITDA |
6.1 | 4.3 | 4.5 | 3.0 | 4.3 | 11.0 | 9.2 | 8.7 | 10.9 | 13.3 | 5.5 | 9.2 | 7.2 | 6.4 | 7.1 | 10.1 | 8.1 | - |
PEG |
0.6 | 1.29 | 0.29 | 0.1 | 0.25 | -2.82 | 0.02 | 0.05 | 0.65 | -0.52 | 2.32 | 0.08 | -5.44 | -0.62 | 0.06 | - | - | - |
P/B |
0.5 | 0.3 | 0.5 | 0.8 | 0.7 | 0.4 | 0.8 | 1.2 | 1.0 | 1.1 | 0.9 | 1.7 | 1.7 | 1.9 | 2.6 | 1.6 | - | - |
P/CF |
14.2 | 5.7 | 4.4 | 4.6 | 6.8 | 5.4 | -43.8 | 27.0 | 82.7 | 25.7 | 10.7 | 13.3 | 76.6 | 21.8 | 26.0 | 14.6 | 20.2 | - |
ROE % |
4.48 | 1.52 | 9.48 | 29.72 | 15.17 | 6.83 | -11.62 | 4.52 | -1.11 | 3.11 | 10.50 | 9.61 | 14.07 | 16.11 | 21.60 | 9.48 | 27.60 | - |
ROA % |
2.21 | 0.76 | 5.06 | 15.32 | 7.40 | 3.37 | -5.53 | 2.34 | -0.58 | 1.77 | 5.75 | 5.63 | 10.44 | 11.56 | 15.93 | 6.51 | - | - |
ROCE % |
6.80 | 5.41 | 10.89 | 39.70 | 22.97 | 4.23 | 2.20 | 5.26 | 2.81 | 2.08 | 8.32 | 8.52 | 13.54 | 18.11 | 19.22 | 14.57 | 28.20 | - |
Current Ratio |
- | - | - | - | - | - | 1.4 | 1.7 | 2.3 | 2.1 | 2.0 | 3.4 | 3.9 | 3.4 | 3.5 | - | - | - |
DSO |
33.2 | 39.1 | 39.6 | 30.8 | 35.6 | 35.4 | 40.3 | 37.6 | 38.6 | 41.1 | 45.1 | 40.6 | 52.0 | 31.7 | 36.2 | - | - | - |
DIO |
106.3 | 96.3 | 96.4 | 85.8 | 89.3 | 91.4 | 94.6 | 102.4 | 86.0 | 79.9 | 79.5 | 88.0 | 78.8 | 56.3 | 67.8 | - | - | - |
DPO |
41.9 | 44.1 | 39.1 | 34.9 | 40.5 | 34.7 | 31.0 | 35.2 | 30.1 | 27.1 | 26.5 | 40.8 | 38.6 | 41.5 | 50.4 | - | - | - |
Operating Cycle |
139.5 | 135.4 | 135.9 | 116.6 | 124.9 | 126.8 | 134.9 | 140.0 | 124.6 | 121.0 | 124.6 | 128.5 | 130.8 | 88.0 | 104.0 | - | - | - |
Cash Conversion Cycle |
97.6 | 91.3 | 96.9 | 81.8 | 84.5 | 92.1 | 103.9 | 104.8 | 94.6 | 93.9 | 98.2 | 87.7 | 92.2 | 46.5 | 53.6 | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios The Mosaic Company
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.81 | 1.3 | 1.29 | 0.75 | - | 0.38 | -0.5 | 0.14 | - | -0.01 | 1.11 | 1.3 | - | 2.45 | 2.88 | 3.23 | - | 0.98 | 1.15 | 0.41 | - | -0.02 | 0.13 | -0.54 | - | -0.11 | -0.6 | 0.34 | - | 0.64 | 0.18 | 0.11 | - | 0.65 | 0.28 | - | - | 0.11 | -0.03 | 0.73 | - | 0.45 | 1.08 | 0.81 | - | 0.54 | 0.65 | 0.54 | - | 0.29 | 1.01 | 0.89 | 1.48 | 0.98 | 2.49 | 1.01 | 1.41 | 1.18 | 1.41 | 1.18 |
EBITDA per Share |
-0.18 | 1.94 | 1.6 | 1.83 | - | 1.11 | 1.55 | 1.29 | - | 1.16 | 1.85 | 2.28 | - | 4.02 | 5.34 | 4.05 | - | 2.34 | 1.81 | 1.38 | - | 0.8 | 0.79 | 0.4 | - | 0.91 | -0.05 | 1.09 | - | 1.58 | 1.07 | 0.78 | - | 1.09 | 0.74 | 0.54 | - | 0.69 | 0.58 | 0.99 | - | 1.2 | 1.94 | 1.37 | - | 1.24 | 1.56 | 1.1 | - | 0.73 | 1.63 | 1.52 | 1.66 | 1.84 | 3.42 | 1.76 | 2.07 | 1.9 | 2.07 | 1.9 |
ROE % |
6.36 | 9.57 | 4.98 | 2.05 | 0.03 | -0.01 | 1.91 | 6.88 | 6.51 | 13.68 | 22.42 | 29.50 | 25.90 | 29.41 | 26.47 | 19.40 | 9.37 | 9.31 | 6.29 | -0.06 | -1.69 | -2.17 | -4.64 | -3.71 | -1.59 | 0.79 | 1.92 | 4.86 | 3.44 | 5.81 | 4.44 | 3.77 | 3.37 | 3.78 | 1.30 | 2.97 | 2.98 | 4.66 | 8.35 | 11.55 | 8.87 | 10.76 | 11.40 | 9.33 | 6.24 | 7.34 | 9.26 | 10.30 | 8.26 | 13.07 | 15.29 | 20.32 | 20.54 | 21.26 | 22.24 | 18.76 | 19.70 | 4.31 | 5.36 | 4.52 |
ROA % |
3.34 | 4.91 | 2.53 | 1.03 | 0.01 | -0.01 | 1.06 | 3.68 | 3.48 | 7.07 | 12.13 | 12.30 | 10.40 | 12.44 | 8.85 | 9.63 | 4.59 | 4.56 | 3.03 | -0.03 | -0.82 | -1.05 | -2.22 | -1.78 | -0.76 | 0.47 | 1.04 | 2.46 | 1.78 | 3.00 | 2.29 | 1.95 | 1.74 | 1.97 | 0.69 | 1.69 | 1.70 | 2.62 | 4.63 | 6.39 | 4.86 | 5.97 | 6.40 | 5.35 | 3.65 | 4.29 | 5.38 | 5.97 | 4.78 | 8.38 | 10.19 | 14.33 | 14.96 | 15.30 | 16.11 | 13.72 | 14.48 | 3.25 | 3.95 | 3.33 |
ROCE % |
4.34 | 8.46 | 7.78 | 7.23 | 4.36 | 5.55 | 7.53 | 10.07 | 8.65 | 18.49 | 31.36 | 39.07 | 34.55 | 41.18 | 36.02 | 25.22 | 14.57 | 15.59 | 9.86 | 4.49 | 1.23 | 2.75 | -0.91 | 0.39 | 1.09 | 4.87 | 5.24 | 8.65 | 6.45 | 8.67 | 5.87 | 4.30 | 3.52 | 4.25 | 2.15 | 2.87 | 2.56 | 5.14 | 9.76 | 12.98 | 11.27 | 13.86 | 15.05 | 12.19 | 8.85 | 10.12 | 12.18 | 12.76 | 10.27 | 14.55 | 18.40 | 23.51 | 24.26 | 27.03 | 27.88 | 24.96 | 26.14 | 5.97 | 6.85 | 6.27 |
DSO |
31.6 | 28.7 | 33.1 | 38.0 | - | 37.6 | 40.5 | 42.3 | - | 33.7 | 35.6 | 39.6 | - | 16.2 | 13.0 | 35.6 | - | 26.9 | 29.0 | 34.4 | - | 33.8 | 39.3 | 42.8 | - | 26.6 | 33.7 | 39.5 | - | -33266.6 | 45007.7 | -20477.3 | - | 5983.4 | 10109.9 | -579620.0 | - | -33698.1 | -4181.5 | 23776.1 | - | -47379.8 | 68437.5 | -46583.1 | - | -16790.0 | -31290.5 | -17938.9 | - | 19823.2 | 9530.4 | 27.3 | 27.5 | 27.0 | 13.6 | 34.8 | 25.8 | 25.3 | 28.0 | - |
DIO |
110.7 | 99.8 | 107.3 | 114.1 | - | 104.4 | 97.1 | 102.6 | - | 81.4 | 104.5 | 106.7 | - | 44.9 | 43.0 | 111.5 | - | 79.8 | 90.3 | 88.2 | - | 78.3 | 88.8 | 99.1 | - | 76.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
38.0 | 39.0 | 40.4 | 44.8 | - | 42.5 | 35.9 | 40.4 | - | 34.0 | 36.5 | 36.1 | - | 14.2 | 11.0 | 38.8 | - | 35.1 | 37.6 | 37.5 | - | 34.6 | 39.3 | 37.6 | - | 25.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 128.6 | 140.4 | 152.0 | - | 142.0 | 137.6 | 144.8 | - | 115.1 | 140.2 | 146.3 | - | 61.1 | 56.0 | 147.1 | - | 106.7 | 119.3 | 122.6 | - | 112.1 | 128.1 | 141.9 | - | 103.2 | 33.7 | 39.5 | - | -33266.6 | 45007.7 | -20477.3 | - | 5983.4 | 10109.9 | -579620.0 | - | -33698.1 | -4181.5 | 23776.1 | - | -47379.8 | 68437.5 | -46583.1 | - | -16790.0 | -31290.5 | -17938.9 | - | 19823.2 | 9530.4 | 27.3 | 27.5 | 27.0 | 13.6 | 34.8 | 25.8 | 25.3 | 28.0 | - |
Cash Conversion Cycle |
- | 89.6 | 100.1 | 107.2 | - | 99.4 | 101.7 | 104.5 | - | 81.1 | 103.6 | 110.2 | - | 46.8 | 45.0 | 108.3 | - | 71.5 | 81.8 | 85.1 | - | 77.5 | 88.8 | 104.2 | - | 78.1 | 33.7 | 39.5 | - | -33266.6 | 45007.7 | -20477.3 | - | 5983.4 | 10109.9 | -579620.0 | - | -33698.1 | -4181.5 | 23776.1 | - | -47379.8 | 68437.5 | -46583.1 | - | -16790.0 | -31290.5 | -17938.9 | - | 19823.2 | 9530.4 | 27.3 | 27.5 | 27.0 | 13.6 | 34.8 | 25.8 | 25.3 | 28.0 | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company The Mosaic Company, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Financial Ratios of other stocks in the Agricultural inputs industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Акрон
AKRN
|
- | - | - |  Russia |
 |
ФосАгро
PHOR
|
- | - | - | Russia |
 |
China Green Agriculture
CGA
|
- | 0.51 % | $ 27.6 M |  China |
 |
Origin Agritech Limited
SEED
|
$ 1.0 | - | $ 7.49 M | China |
 |
The Scotts Miracle-Gro Company
SMG
|
$ 65.68 | -3.87 % | $ 3.78 B |  USA |
 |
CVR Partners, LP
UAN
|
$ 128.99 | 0.78 % | $ 1.36 B | USA |
 |
American Vanguard Corporation
AVD
|
$ 2.39 | -2.85 % | $ 67.9 M | USA |
 |
CF Industries Holdings
CF
|
$ 125.19 | -0.46 % | $ 20.3 B | USA |
 |
FMC Corporation
FMC
|
$ 10.71 | -9.47 % | $ 1.34 B | USA |
 |
Marrone Bio Innovations
MBII
|
- | -5.9 % | $ 180 M | USA |
 |
Yield10 Bioscience
YTEN
|
- | 15.32 % | $ 46.6 M | USA |
 |
Bioceres Crop Solutions Corp.
BIOX
|
$ 0.36 | 11.46 % | $ 22.8 M |  Argentina |
 |
Corteva
CTVA
|
$ 78.71 | -11.93 % | $ 53.5 B | USA |
 |
ICL Group Ltd
ICL
|
$ 5.06 | -2.32 % | $ 6.53 B |  Israel |
 |
Arcadia Biosciences
RKDA
|
$ 0.63 | -3.83 % | $ 862 K | USA |
 |
Intrepid Potash
IPI
|
$ 33.96 | -3.85 % | $ 442 M | USA |
 |
Nutrien Ltd.
NTR
|
$ 69.07 | -2.33 % | $ 33.6 B |  Canada |